Logo image of SYNX

SILYNXCOM LTD (SYNX) Stock Fundamental Analysis

NYSEARCA:SYNX - NYSE Arca - IL0011990749 - Common Stock - Currency: USD

1.86  +0.01 (+0.54%)

After market: 1.82 -0.04 (-2.15%)

Fundamental Rating

3

Overall SYNX gets a fundamental rating of 3 out of 10. We evaluated SYNX against 65 industry peers in the Aerospace & Defense industry. SYNX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SYNX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SYNX has reported negative net income.
SYNX had a negative operating cash flow in the past year.
SYNX Yearly Net Income VS EBIT VS OCF VS FCFSYNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 1M -1M -2M

1.2 Ratios

SYNX has a worse Return On Assets (-39.38%) than 78.46% of its industry peers.
With a Return On Equity value of -53.13%, SYNX is not doing good in the industry: 70.77% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -39.38%
ROE -53.13%
ROIC N/A
ROA(3y)-5.91%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SYNX Yearly ROA, ROE, ROICSYNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 100 -100 200

1.3 Margins

The Gross Margin of SYNX (44.80%) is better than 86.15% of its industry peers.
The Profit Margin and Operating Margin are not available for SYNX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SYNX Yearly Profit, Operating, Gross MarginsSYNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

SYNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SYNX has about the same amount of shares outstanding.
The debt/assets ratio for SYNX has been reduced compared to a year ago.
SYNX Yearly Shares OutstandingSYNX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M 4M 5M
SYNX Yearly Total Debt VS Total AssetsSYNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

An Altman-Z score of 5.63 indicates that SYNX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.63, SYNX is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
SYNX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
SYNX has a better Debt to Equity ratio (0.00) than 90.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.63
ROIC/WACCN/A
WACC8.76%
SYNX Yearly LT Debt VS Equity VS FCFSYNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 1M -1M 2M -2M

2.3 Liquidity

SYNX has a Current Ratio of 4.10. This indicates that SYNX is financially healthy and has no problem in meeting its short term obligations.
SYNX has a Current ratio of 4.10. This is amongst the best in the industry. SYNX outperforms 84.62% of its industry peers.
A Quick Ratio of 2.88 indicates that SYNX has no problem at all paying its short term obligations.
SYNX has a Quick ratio of 2.88. This is amongst the best in the industry. SYNX outperforms 87.69% of its industry peers.
Industry RankSector Rank
Current Ratio 4.1
Quick Ratio 2.88
SYNX Yearly Current Assets VS Current LiabilitesSYNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SYNX have decreased strongly by -568.79% in the last year.
The Revenue has grown by 25.38% in the past year. This is a very strong growth!
EPS 1Y (TTM)-568.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.35%
Revenue 1Y (TTM)25.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y106.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SYNX Yearly Revenue VS EstimatesSYNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M
SYNX Yearly EPS VS EstimatesSYNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 0 -0.2 -0.4 -0.6 -0.8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SYNX. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 30.39, SYNX can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, SYNX is valued a bit cheaper than the industry average as 63.08% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of SYNX to the average of the S&P500 Index (20.42), we can say SYNX is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 30.39
SYNX Price Earnings VS Forward Price EarningsSYNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SYNX Per share dataSYNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

SYNX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SYNX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SILYNXCOM LTD

NYSEARCA:SYNX (5/8/2025, 6:30:20 PM)

After market: 1.82 -0.04 (-2.15%)

1.86

+0.01 (+0.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners12.89%
Inst Owner ChangeN/A
Ins Owners73.93%
Ins Owner ChangeN/A
Market Cap12.33M
AnalystsN/A
Price TargetN/A
Short Float %1.13%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 30.39
P/S 0.95
P/FCF N/A
P/OCF N/A
P/B 1.86
P/tB 1.86
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)0.06
Fwd EY3.29%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS1.96
BVpS1
TBVpS1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.38%
ROE -53.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.8%
FCFM N/A
ROA(3y)-5.91%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.45%
Cap/Sales 0.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.1
Quick Ratio 2.88
Altman-Z 5.63
F-Score4
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)36.28%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.45%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-568.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.35%
EPS Next Y106.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%73%
Revenue Next Year50%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y141.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y141.98%
OCF growth 3YN/A
OCF growth 5YN/A